Project Destiny Summary

Similar documents
COMMUNICATION STRATEGY. Table of Contents

ABPI 3 YEAR STRATEGIC PLAN

The BIG question: What s different about a customer-driven business transformation?

.COM. Pharmaceutical Brand Management Achieving Managed Care Pull-Through Performance

Strategic Plan. Uniting to care & cure

Developing Drugs for Rare Diseases: Patient Advocacy s Perspective. Kristina Bowyer Executive Director, Patient Advocacy

THE HEALTHCARE SUPPLY CHAIN LEADER OF THE FUTURE

CPhA Strategic Plan

The Path to Clinical Enterprise Maturity DEVELOPING A CLINICALLY INTEGRATED NETWORK

Policy principles for a competitive healthcare environment

A High-Touch Approach to Improving Patient Access. Using field support to navigate reimbursement challenges

Rx EDGE. Retail strategy considerations for the launch of a new product or indication. White Paper. Pharmacy Networks

Policies Approved by the 2018 ASHP House of Delegates

Core Values and Concepts

The Journey to Shared Value

UPS Healthcare Supply Chain Vital Signs

Road Map to Starting a Specialty Pharmacy

For pharmaceutical and medical products

Cutting Edge Information

Industry Overview & Strategic Growth Framework

Delivered by Sandra Fuller, MA, RHIA, FAHIMA. April 29, 2009

HIE.Next: Building an API-centric Infrastructure for Health Information Exchange

Successful healthcare analytics begin with the right data blueprint

HOW TO IDENTIFY & PRIORITIZE TRIAL STAKEHOLDERS

Strategic Plan. Uniting to care & cure

When customers are the cure

1. How innovation changes your organization s competitive advantage

New Cardinal Health (Post-Spin)

2017 to 2020 Strategic Plan. Approved by the CAA Board of Directors: March 1, 2017

Maximizing Market Access: THE 5 MOST CRITICAL QUESTIONS TO ASK WHEN LAUNCHING A SPECIALTY DRUGS

I D C T E C H N O L O G Y S P O T L I G H T

CRITICAL SUCCESS FACTORS

2012 Healthcare (Pharmaceutical) Industry Perspective

COLORADO MULTI-PAYER COLLABORATIVE

Partnering for Change: Addressing Revenue Cycle with Interim Management

How Information Transformation Drives Healthcare Performance

Q Results & Acquisition of Tea Leaves Health

Membership Goal. Donor Goal. NCSEA Diversity & Inclusion Initiative Action Plan. Impact on the Community. Impact on NCSEA. Strategies to reach goal

STRATEGIC PLAN

Optimizing the Impact of the Medical Affairs Function

Our comments include three recommendations and the associated rationale:

Build, Buy, or Align: Creating Clinically Integrated Health Systems

HEALTH PURCHASING VICTORIA STRATEGY. December 2017

Summary of the Actions of the ASHP House of Delegates. June 3 and 5, 2018

IDEA TO IMPACT: Guide to Introduction and Scale of Global Health Innovations. Toolkit Overview

Physician Marketing & Outreach Growing Referring Physician Lifetime Value

Change Healthcare Performance Analytics. Identify Opportunities for Financial, Clinical, and Operational Improvement

survive or thrive? becoming a successful value-based enterprise

Kids Central Inc. Strategic Plan

Objectives. Virginia Community Pharmacy Enhanced Services Network. VA CPESN Leadership

THE API ECONOMY WHY PUBLIC APIS ARE SO IMPORTANT AUTHORS

Medical products companies recognize the potential. Building a Sustainable Targeting Capability in Medical Device Companies

Visionary Leadership. Systems Perspective. Student-Centered Excellence

Terms of Reference Follow-up Study UNITED NATIONS PERCEPTION SURVEY IN RWANDA. National Consulting Firm

Community Transformation Workforce. Clare Hines Health Education England SW Associate Director Workforce Strategy & Planning

Driving sustainability at scale Strategy 2020

WHITE PAPER. Engaging the Evolving Stakeholder Network: A New Approach for Medical Affairs

STRATEGIC FRAMEWORK. National CASA Association

Specialty Pharmacy: Issues and Opportunities

SPECIALTY PHARMACY : ARE YOU MISSING OUT ON A VIABLE REVENUE STREAM. January 16, 2018

STRATEGIC PLAN

Understanding Payer Dynamics. A critical factor in maximizing brand performance. Healthcare Measurement IMS Payer Insights

Director Procurement & Value Delivery

Developing a Policy & Governance Framework for an Operational Learning Health System Discussion with the NCHICA Informatics & Analytics Roundtable

Vision/Mission Statements Adopted on November 2, 2015

Ontario Hospital Association. Strategic Plan

Re-defining the Strategic Change Programme

37 th Annual J.P. Morgan Healthcare Conference

2016 European Telehealth and Telecare Solutions Market Leadership Award

econsult considerations for implementation in California s healthcare safety net

Optum Performance Analytics

CON-RCO Public Engagement Initiative Strategic Plan

Core Strategy Report"

The Future of Pharmaceutical Quality

Hospital-Physician Alignment: Managing Change in the Shifting Health Care Environment

Telehealth Program Development Toolkit

Optum Performance Analytics

US Pharmacy Benefit Management Market Report

Innovative Approaches to Saving Patients Money on Prescription Drug Costs

International Pharmaceutical Federation (FIP) CEO

The New Role of Medical Affairs in Defining and Driving Product Success

Catholic Family Services Peel-Dufferin. Executive Summary. Strategic Plan to 2018 June 2015

Health Information. for Government. Maximize the Value of Your Health Information Exchange

IBM Enterprise Service Bus for Healthcare

EPSA EC CONSULTATION:

BRITISH GENERIC MANUFACTURERS ASSOCIATION

May 9, Meeting Summary. Facilitating Antibacterial Drug Development

IRS Enterprise Concept of Operations (CONOPS) Overview of SB/SE and W&I, LB&I, and TE/GE CONOPS. Deloitte Consulting LLP January 15, 2015

Advanced Contracting Course

34 th Annual J.P. Morgan Healthcare Conference

Degree of Differentiation Low < Medium > High market data. feedback.

Global Alliance for Genomics and Health Strategic Road Map (2015/2016)

Aligning an Association with Member Needs Jorge Restrepo, M.G.A. CEO & Chief Analyst at EurekaFacts, LLC

WHAT IF DRUG DATA WAS MORE THAN JUST DATA?

Core Values and Concepts

AN AGILE OPERATING MODEL FOR THE DIGITAL AGE NICHOLAS BAYLEY DIANA BERSOHN AAMER CHAUDHRY STEVE PONIATOWSKI

BIOTECH, MED DEVICE & PHARMA

Queensland Health Transforming Procurement

A Framework for Audit Quality

Specialty Pharmacy: Inside the Innovation. Tim Davis, Pharm.D. General Manager PANTHERx Specialty Pharmacy

Transcription:

Project Destiny Summary The American Pharmacists Association (APhA), the National Association of Chain Drug Stores (NACDS), and the National Community Pharmacists Association (NCPA) have joined together for an industry changing initiative, Project Destiny. The initial phase of the project has succeeded in defining both the specific challenges facing community pharmacy and the opportunities it has to expand beyond a commoditized dispensing entity. This meets the core objective originally defined for the project: to develop related health product information for a replicable, scalable, measurable, and economically viable future model for community pharmacy. The Project accomplished this by: Evaluating the current position of community pharmacy, consumer needs and market trends through the view of multiple healthcare stakeholders Identifying core service offerings that leverage the assets of community pharmacy, health information exchange, and interoperability Key Findings Throughout the Project the three associations, working with BearingPoint, conducted detailed market research, performed comprehensive economic analyses, and solicited direct healthcare stakeholder feedback from organizations and individuals who are leaders within healthcare. This led to a number of key findings that provide insight to community pharmacy for the future: Finding A Significant Unmet Consumer Need Exists in the Market: A Viable Market Opportunity Exists: Pharmacists are Well Positioned to Address Unmet Needs: The Market is Being Defined: Healthcare Stakeholders Want to be Engaged in the Process: Significant Hurdles Exist: Description There are a host of unmet consumer needs stemming from market issues that were consistently validated across the market, including lack of medication management, the increase of chronic and comorbid conditions, lack of healthcare economic sustainability, avoidable healthcare costs, and the shortage of outcomes evidence Services that address the unmet needs in the market have the potential to yield positive revenues for community pharmacy starting in year one with growth to over $7.5 billion in yearly revenues within five years Community pharmacists have the capability to address unmet needs, are an underutilized resource, and can leverage their local and diverse access to differentiate services for targeted consumer groups The medication management market is rapidly filling with competition from other healthcare providers (e.g., nurses and physicians) and organizations (e.g., payers and pharmacy benefit managers), community pharmacy will lose the opportunity to compete in the market if it does not define its role immediately Healthcare Stakeholders, most specifically payers, consistently voiced their strong desire to be engaged in the process of developing the service offerings and to collaborate on bringing the services to market Negative market biases and healthcare stakeholder perceptions of community pharmacists inability to offer expanded services Development and reinforcement of a commitment to change from a transaction based to a relationship based model The challenge in uniting the community pharmacy industry to support a core service offering Regulatory restrictions related to pharmacists/pharmacist extenders Lack of needed infrastructure to support the expanded offerings Significant level of investment required to build broad market service offerings Lack of relationships between pharmacists and consumers despite the consistent opportunity to establish them Time constraints on pharmacists due to increasing demand for prescriptions Project Destiny Summary 1

It is also important to note there was near unanimous agreement across healthcare stakeholder groups that community pharmacy will cease to be a relevant player in patient care and medication management if it does not commit to a significant transformation the time for change is now. The Vision for the Future Fundamental to the future vision and model for community pharmacy are two key concepts: Primary Care Pharmacist: The introduction of the new service offerings will include a campaign targeted to consumers, physicians and payers to establish the concept of the community pharmacist as primary care pharmacist and change key healthcare stakeholder perceptions about community pharmacists willingness to provide medication management and clinical services. The primary care pharmacists will demonstrate their value by assisting patients and their providers in the overall management of medications and conditions across providers. The primary care pharmacist will use data and insight to assist in addressing overall patient management with a specific focus on issues linked to the management of multiple conditions and the use of multiple providers. Patient Care Management Services: A set of clinical interventions that go beyond a narrow definition of medication therapy management to include a set of condition specific interventions targeting the 15 conditions plus polypharmacy that drive a disproportionate level of avoidable healthcare utilization. The patient care management services leverage the pharmacist s clinical knowledge and skills related to medication management and address the consumers healthcare questions and educational needs. A key differentiator within the patient care management services is a core set of interventions delivered to the patient through face-to-face interventions. The collection and reporting of intervention and outcomes data to the key healthcare stakeholders is a core component of the service offering. The following three key transitional themes set the stage for the future vision of community pharmacy: Consumer interaction that is enhanced by providing a broad set of clinical and retail services and by acknowledging the potential benefits of medication management interventions for various consumers that access the community pharmacy Transition from a transaction oriented dispensing pharmacist to a primary care pharmacist who establishes a sustainable relationship with patients/consumers and provides medication management services across multiple conditions and in collaboration with other healthcare providers Taking a leadership role in the collection and analysis of medication related health outcomes data and becoming an integral component of health information exchange that allows the data to be utilized broadly within the healthcare delivery system through the integration of e-prescribing, electronic health records and personal health records Based upon these themes, Project Destiny developed two models for consideration, with one model more favourably meeting both business and legal requirements while: Project Destiny Summary 2

Delivering the vision of a new Community Pharmacy Service Model Pharmacies across geographies will deliver a core service offering of Patient Care Management Services to consumers in collaboration with payers regardless of which type of community pharmacy the consumer selects Fostering a consistent infrastructure based on standards Standards (e.g. HIE) provide the foundation for service and operations infrastructures that: Ensure service obligations to consumers and payers are met Ensures an efficient operational delivery within a pharmacy organization providing services to multiple consumers and payers Protecting the consistency of the service offering while maintaining the autonomy of individual pharmacies A set of core elements & associated standards provide the necessary consistency across community pharmacy while allowing: Independent pricing & contracting at the pharmacy organization level The ability to enhance the core elements at the pharmacy organization level This model will guide community pharmacy to become a more integral part of the healthcare delivery system. It will strengthen pharmacists relationships with key healthcare stakeholders to work collaboratively to manage medications, positively impact health outcomes, reduce overall healthcare system costs, and empower consumers to actively manage their health. However, anything less than consistent movement to achieve the vision will reinforce the current market perception that community pharmacy is fragmented and unable to deliver beyond core dispensing services. Service Offering Recommendations Based on the Project findings, it is clear that now is the time for community pharmacy to make the transition from a transaction based, commoditized dispensing model to a relationship based, consumer-centric model. At the core of the future model for community pharmacy are patient care management services. There are a number of organizations and initiatives that address some of these services (Asheville, Mirixa, Outcomes). Mirixa is an example of an organization that has, as part of its service offering, many of the key components that are outlined in the related health product information. The new business model depends on leveraging these initiatives and redefining them in collaboration with the payers and healthcare funders, and, by doing so, it will address two critical success factors: Building an integrated infrastructure that will increase information sharing across healthcare providers, establish increased visibility to a patient s entire treatment, and enhance the treatment options available Defining a scalable and repeatable model that can succeed beyond the individual pharmacy or collection of pharmacies at the regional level This phase of Project Destiny has defined a solution that addresses these critical success factors through service offerings that will meet consumer needs and an overall implementation approach to bring them to market. The Service Offering Model is driven by consumer needs related to three target consumer segments: Project Destiny Summary 3

Segment High Utilizers Future Chronics Health & Wellness Description Consumers with chronic conditions who drive the majority of the healthcare spend and utilizers with healthcare status that drives avoidable spending Consumers over 41 years, not otherwise included, that have an increased likelihood to have a chronic condition in the near to mid term and increased risk factors for the target conditions Consumers already committed to health and wellness with a strong probability of willingness to pay for services based on high derived value The Model aligns services that are managed and delivered directly to consumers by a primary care community pharmacist: Dispensing and Administering Services related to the coordinated preparation, filling, and delivery of a customer s prescription medications as well as administering of other medications (e.g., vaccinations). Patient Care Management Services that leverage the pharmacist s clinical knowledge and skills related to medication management to address a customer s health issues or concerns. Related Health Product Information Services designed to augment a customer s total medication experience through the pharmacist s recommendations based on prescriptions, purchases or customer profile. In addition to the services delivered directly to consumers by a primary care pharmacist, the model includes Consumer, Service, and Outcomes Data services. These services focus on reporting detailed and aggregated data related to patients, services, and outcomes to prescribers, payers, funders, and consumers. Personal Health Records serve as a core element of the data collection process and the mechanism to engage consumers in sharing health data. Revenue Potential There is a solid revenue opportunity projected for each of the identified service offerings. These projections show that revenues become increasingly attractive over time as more consumers utilize the proposed service offerings. Project Destiny Summary 4

To provide context for these incremental revenue projections, the year ten estimate of $59 billion for the delivery of services to community pharmacy target segments represents approximately $920,000 per community pharmacy ($59 billion across 64,000 community pharmacies represented by NACDS and NCPA). In the future, reimbursement models will allow owners and operators to calculate the specific impact to their pharmacies. Transforming Community Pharmacy Through the initiation of Project Destiny, APhA, NACDS, and NCPA have developed an approach for guiding community pharmacy to a stronger position in the healthcare market. This approach has been informed based on feedback from healthcare stakeholder interviews and is built upon: Continuing to build strong relationships with key healthcare stakeholders Supporting the introduction of expanded services Building credibility through the demonstration of community pharmacy s capabilities and commitment as a whole toward its new vision Developing acceptance of community pharmacy s role in the market Employing communications as a strategic activity that focuses on healthcare stakeholders specific needs through tailored outreach initiatives that deliver tested core messages By following this approach, community pharmacy will benefit from the support and advocacy it receives from healthcare stakeholders, the increased opportunities for needed reimbursement, and the position it establishes as the preferred source of medication management services. Modernizing the community pharmacy practice and business model will be one of the most important and significant undertakings the industry has ever pursued. The transformation goes beyond simply addressing competition from PBMs and mailorder pharmacy or the introduction of in-store clinics occurring across the country. This is an effort to move an entire profession and industry. It is important to note that the future business model will leverage existing initiatives that are currently in Project Destiny Summary 5

the market (Asheville, Mirixa, Outcomes), and similar initiatives that may already exist or may emerge, as the intent of Project Destiny is not to redevelop work that has already been done. Even so, the related health product information will transform the way that pharmacy is perceived and its position within the healthcare system. This is not a quick fix and it is recognized that the related health product information included in this final report are disruptive to the current environment requiring: A belief in the power of the profession to make an impact on health care outcomes A desire to participate in the medication management market space A willingness to collaborate with community pharmacy stakeholders in new ways to expand pharmacy services in a manner that benefits the profession and preserves the economic viability of community pharmacy A commitment to invest in the realization of the future vision both philosophically and financially A demonstration of leadership to energize and engage community pharmacists in the vision of an enhanced future With these in place, the journey developed for the transformation of community pharmacy moves through specific states over the course of a ten year or more timeframe (See the Implementation Strategy for an overview of each state): Credible & Prepared Proven & Mobilized Recognized & Integrated Healthcare Delivery Partner 2009 2011 2013 2017 Although it will be a long journey to successfully transform community pharmacy, action must be taken now, starting at the end of 2007, to seize the opportunity in the market. Community pharmacy will ensure that it is taking the necessary steps to progress along its journey and begin addressing unmet market needs by conducting the following activities over the next 6 months: Engage association membership on the outcomes of the initial phase of work and reinforce the urgency for change Maintain and expand the healthcare stakeholder network developed during initial phase of work to identify collaborators and to continue to educate the community regarding pharmacy s transformation Conduct research on legal and regulatory needs to facilitate the transformation and deliver the service offering Develop the funding plan for the next phases of work Outline the specific tactics that community pharmacies can implement to educate healthcare stakeholders Following quickly from these immediate next steps, community pharmacy must focus its attention on building credibility and preparing for transformation through coordinated pilots and other related activities. There is an opportunity to work closely with payers and healthcare funders to define the various pilots while simultaneously demonstrating the ability of community pharmacy to deliver patient care management services. By capitalizing on this opportunity, community pharmacy will demonstrate scalability of the new business model, credibility in delivery, and highlight the difference pharmacy led interventions make in health care outcomes compared to those delivered by other clinicians. This Project Destiny Summary 6

will diffuse skepticism in the market related to community pharmacy s capacity to transform and build critical relationships with consumers. Beyond the pilots, there is a set of activities that can be implemented in the nearterm to prepare community pharmacy for the transformation and begin to dispel healthcare stakeholder biases. These activities include the implementation of: A Personal Health Records initiative A relationship management training and tracking initiative A customer interaction process with existing consumers receiving dispensing services Now is when the market is being defined and the healthcare system is looking for answers to pressing needs related to medication management. There is a significant opportunity for community pharmacy to establish market leadership in medication management through the delivery of patient care management services and the demonstration of positive health outcomes and cost offsets. This leadership position, however, can not be created if the market entry is tentative. The cost of waiting to start this transformation is too great to ignore. It is the difference between surviving under protection of legislation and flourishing under a market oriented model that drives improved patient outcomes, increased profits, and better economic sustainability. Project Destiny Summary 7